BiotechTube
Home/MG Biologics/Sarah Meyer Thompson
SM

Sarah Meyer Thompson

CEO / Head Cheerleader

MG Biologics

Therapeutic Areas

Infectious DiseaseVaccines

MG Biologics Pipeline

DrugIndicationPhase
Rhodococcus Equi Antibody OptimizationRhodococcus equi infection in foalsResearch
ImmunoGutGastrointestinal support against E. coli, Parvovirus, Salmonella, C. difficileCommercial
Custom Blend ProgramFarm-specific pathogen combinationsService

Leadership Team at MG Biologics

MM
Mark Meyer
Founder / Owner / Chairman of the Board
View full MG Biologics profile